These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 1553114
1. A comparison of two pancreatin microsphere preparations in cystic fibrosis. Elliott RB, Escobar LC, Lees HR, Akroyd RM, Reilly HC. N Z Med J; 1992 Mar 25; 105(930):107-8. PubMed ID: 1553114 [Abstract] [Full Text] [Related]
3. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis. Delhaye M, Meuris S, Gohimont AC, Buedts K, Cremer M. Eur J Gastroenterol Hepatol; 1996 Jul 25; 8(7):699-703. PubMed ID: 8853261 [Abstract] [Full Text] [Related]
4. Comparison of four pancreatic extracts in cystic fibrosis. Beverley DW, Kelleher J, MacDonald A, Littlewood JM, Robinson T, Walters MP. Arch Dis Child; 1987 Jun 25; 62(6):564-8. PubMed ID: 3304172 [Abstract] [Full Text] [Related]
5. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. Trapnell BC, Maguiness K, Graff GR, Boyd D, Beckmann K, Caras S. J Cyst Fibros; 2009 Dec 25; 8(6):370-7. PubMed ID: 19815466 [Abstract] [Full Text] [Related]
6. Two enteric coated microspheres in cystic fibrosis. Williams J, MacDonald A, Weller PH, Fields J, Pandov H. Arch Dis Child; 1990 Jun 25; 65(6):594-7. PubMed ID: 2198848 [Abstract] [Full Text] [Related]
11. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study. Graff GR, Maguiness K, McNamara J, Morton R, Boyd D, Beckmann K, Bennett D. Clin Ther; 2010 Jan 25; 32(1):89-103. PubMed ID: 20171415 [Abstract] [Full Text] [Related]
12. In vivo and in vitro studies of microsphere pancreatic supplements. Littlewood JM, Kelleher J, Walters MP, Johnson AW. J Pediatr Gastroenterol Nutr; 1988 Jan 25; 7 Suppl 1():S22-9. PubMed ID: 2457072 [Abstract] [Full Text] [Related]
13. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. Morrison G, Morrison JM, Redmond AO, Byers CA, McCracken KJ, Dodge JA, Guilford SA, Bowden MW. Aliment Pharmacol Ther; 1992 Oct 25; 6(5):549-55. PubMed ID: 1420747 [Abstract] [Full Text] [Related]
15. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study. Brady MS, Garson JL, Krug SK, Kaul A, Rickard KA, Caffrey HH, Fineberg N, Balistreri WF, Stevens JC. J Am Diet Assoc; 2006 Aug 25; 106(8):1181-6. PubMed ID: 16863712 [Abstract] [Full Text] [Related]
18. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT. Van de Vijver E, Desager K, Mulberg AE, Staelens S, Verkade HJ, Bodewes FA, Malfroot A, Hauser B, Sinaasappel M, Van Biervliet S, Behm M, Pelckmans P, Callens D, Veereman-Wauters G. J Pediatr Gastroenterol Nutr; 2011 Jul 25; 53(1):61-4. PubMed ID: 21694537 [Abstract] [Full Text] [Related]
20. Comparison of two forms of enteric-coated pancrelipase In six teenagers with cystic fibrosis. Warwick WJ, Budd JR. Clin Ther; 1982 Jul 25; 5(1):15-20. PubMed ID: 7127365 [Abstract] [Full Text] [Related] Page: [Next] [New Search]